{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AMPK", "antidiabetic drugs", "medicinal plants", "natural products", "type 2 diabetes mellitus."]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30484403", "DateCompleted": {"Year": "2019", "Month": "08", "Day": "07"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1389557519666181128120726"], "Journal": {"ISSN": "1875-5607", "JournalIssue": {"Volume": "19", "Issue": "11", "PubDate": {"Year": "2019"}}, "Title": "Mini reviews in medicinal chemistry", "ISOAbbreviation": "Mini Rev Med Chem"}, "ArticleTitle": "Activation of AMPK by Medicinal Plants and Natural Products: Its Role in Type 2 Diabetes Mellitus.", "Pagination": {"StartPage": "880", "EndPage": "901", "MedlinePgn": "880-901"}, "Abstract": {"AbstractText": ["Type-2 Diabetes (T2D) is a metabolic disease characterized by permanent hyperglycemia, whose development can be prevented or delayed by using therapeutic agents and implementing lifestyle changes. Some therapeutic alternatives include regulation of glycemia through modulation of different mediators and enzymes, such as AMP-activated protein kinase (AMPK), a highly relevant cellular energy sensor for metabolic homeostasis regulation, with particular relevance in the modulation of liver and muscle insulin sensitivity. This makes it a potential therapeutic target for antidiabetic drugs. In fact, some of them are standard drugs used for treatment of T2D, such as biguanides and thiazolidindiones. In this review, we compile the principal natural products that are activators of AMPK and their effect on glucose metabolism, which could make them candidates as future antidiabetic agents. Phenolics such as flavonoids and resveratrol, alkaloids such as berberine, and some saponins are potential natural activators of AMPK with a potential future as antidiabetic drugs."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centro de Endocrinologia Experimental y Aplicada, (CONICET-CCT La Plata-UNLP FCM, CEAS CICPBA), Argentina."}], "LastName": "Francini", "ForeName": "Flavio", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "C\u00e1tedra de Farmacolog\u00eda B\u00e1sica, Facultad de Ciencias M\u00e9dicas, Universidad Nacional de La Plata, Argentina."}, {"Identifier": [], "Affiliation": "Comisi\u00f3n de Investigaciones Cient\u00edficas de la Provincia de Buenos Aires, La Plata, Argentina."}], "LastName": "Schinella", "ForeName": "Guillermo R", "Initials": "GR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament de Farmacologia, Facultat de Farmacia, Universitat de Valencia, Valencia, Spain."}], "LastName": "R\u00edos", "ForeName": "Jos\u00e9-Luis", "Initials": "JL"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mini Rev Med Chem", "NlmUniqueID": "101094212", "ISSNLinking": "1389-5575"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biguanides"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Thiazolidinediones"}, {"RegistryNumber": "EC 2.7.11.31", "NameOfSubstance": "AMP-Activated Protein Kinases"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "AMP-Activated Protein Kinases"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Biguanides"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glucose"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Thiazolidinediones"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "5", "Day": "9"}, {"Year": "2018", "Month": "7", "Day": "4"}, {"Year": "2018", "Month": "11", "Day": "22"}, {"Year": "2018", "Month": "11", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "29", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30484403", "10.2174/1389557519666181128120726", "MRMC-EPUB-94845"]}}]}